Int J Pept Res Ther 27:22912301 Wang M-D, Hou D-Y, Lv G-T, Li R-X, Hu X-J, Wang Z-J, Zhang N-Y, Yi L, Xu W-H et al (2021b) Targeted in situ self-assembly augments peptide drug conjugate cell-entry efficiency
That's because Mounjaro is a dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonist, which may make it more effective at controlling blood sugar levels and supporting weight loss
Medically reviewed by Oghenefejiro Okifo | MD , Harvard Medical School | Henry Ford Hospital - Detroit, MI on February 27th, 2024
This is because manufacturing and dispensing dont happen on the same day
The high flexibility and length of the -glutamyl bond formed by glutamic acid and cysteine in GSH contribute to the instability of its interactions with the loop regions